+
Artemis Q4 Revenue up 7%, EBITDA Rises 21%, Net Profit Jumps 60%
ECONOMY & POLICY

Artemis Q4 Revenue up 7%, EBITDA Rises 21%, Net Profit Jumps 60%

The Board of Directors of Artemis Medicare Services today approved the company’s audited financial results for the 4th quarter (Jan to Mar) and 12M (Apr to Mar) for the financial year 2024 – 25.

For the quarter ended March 31, 2025 Artemis Medicare Services, on a consolidated level, registered a gross revenue of Rs 2,521 Million, an increase of 7.0 per cent over the same period last fiscal. For the fiscal year (April – March), the company’s gross revenue closed at Rs 9,819 Million, an increase of 6.5 per cent over the same period last fiscal. The Board of Directors have recommended a final dividend of 45 per cent per Equity Share of face value of Re 1 each for FY25, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the Company.

Commenting on the company’s performance, Onkar Kanwar, Chairman, Artemis Medicare Services said “Artemis concluded FY25 on a strong and positive trajectory, delivering consistent performance and steady growth across the year. We have continued to advance in both clinical excellence and operational capabilities, reaffirming our commitment to provide high-quality, accessible healthcare to the communities we serve. During the year we also inaugurated our third tower, which will be commissioned in a phase-wise manner to accommodate the increasing demand from our growing patient base.

To fuel our next growth phase, we raised Rs 3.30 billion from the International Finance Corporation (IFC), enabling strategic expansion across Delhi NCR and select Tier 2 cities through both brownfield and greenfield projects. The Board has approved a long-term Operations & Management and Medical Services Agreement for a 300+ bed super-speciality hospital in Raipur. This deal marks a key step in expanding our footprint in Central India and reinforces our mission to deliver advanced healthcare solutions across geographies. As we look ahead, our unwavering focus remains on creating long-term value for our patients, shareholders, and employees, while building Artemis into one of India’s most trusted and respected healthcare brands.”

The Board of Directors of Artemis Medicare Services today approved the company’s audited financial results for the 4th quarter (Jan to Mar) and 12M (Apr to Mar) for the financial year 2024 – 25.For the quarter ended March 31, 2025 Artemis Medicare Services, on a consolidated level, registered a gross revenue of Rs 2,521 Million, an increase of 7.0 per cent over the same period last fiscal. For the fiscal year (April – March), the company’s gross revenue closed at Rs 9,819 Million, an increase of 6.5 per cent over the same period last fiscal. The Board of Directors have recommended a final dividend of 45 per cent per Equity Share of face value of Re 1 each for FY25, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the Company.Commenting on the company’s performance, Onkar Kanwar, Chairman, Artemis Medicare Services said “Artemis concluded FY25 on a strong and positive trajectory, delivering consistent performance and steady growth across the year. We have continued to advance in both clinical excellence and operational capabilities, reaffirming our commitment to provide high-quality, accessible healthcare to the communities we serve. During the year we also inaugurated our third tower, which will be commissioned in a phase-wise manner to accommodate the increasing demand from our growing patient base.To fuel our next growth phase, we raised Rs 3.30 billion from the International Finance Corporation (IFC), enabling strategic expansion across Delhi NCR and select Tier 2 cities through both brownfield and greenfield projects. The Board has approved a long-term Operations & Management and Medical Services Agreement for a 300+ bed super-speciality hospital in Raipur. This deal marks a key step in expanding our footprint in Central India and reinforces our mission to deliver advanced healthcare solutions across geographies. As we look ahead, our unwavering focus remains on creating long-term value for our patients, shareholders, and employees, while building Artemis into one of India’s most trusted and respected healthcare brands.”

Next Story
Infrastructure Transport

Work Begins on Rs 6.5 Billion Goregaon-Mulund Link Road Tunnels

Work on the twin tunnels of the ambitious Rs 6.5 billion Goregaon-Mulund Link Road (GMLR) project is set to commence next month. Several trailers carrying components of the Tunnel Boring Machine (TBM) intended for excavating the tunnels have arrived in Mumbai from Japan. The final shipment of the first TBM parts is expected next month, paving the way for construction to begin.Phase 3(B) of the GMLR project will develop a 6.65-kilometre corridor, including a 1.22-kilometre triple-lane box tunnel at Film City and twin tunnels beneath Sanjay Gandhi National Park (SGNP).The tunnels will start at F..

Next Story
Infrastructure Transport

New High-Speed Corridor to Cut Delhi-Gurugram Travel Time

Fed up with long traffic jams between Delhi and Gurugram? Relief may be near as plans for a new high-speed corridor are underway, set to drastically reduce travel time between the two cities. What currently takes over an hour on congested routes such as NH-48 or MG Road could soon be shortened to just 25 to 30 minutes.A direct link originating from either Gyarah Murti or Talkatora Stadium to Gurugram is being explored as part of two key proposals designed to ease traffic congestion in Lutyens’ Delhi and Central Delhi, according to government sources.The concept was discussed at a meeting in ..

Next Story
Infrastructure Transport

Vertis Raises Rs 9 billion via SLB, Sets InvIT Benchmark

Vertis Infrastructure Trust (formerly Highways Infrastructure Trust), a SEBI-registered Infrastructure Investment Trust (InvIT), has raised Rs 9 billion through a Sustainability-Linked Bond (SLB), the largest such issuance by an Indian InvIT to date. The 10-year fixed-rate bond, priced at 7.40 per cent, was anchored by the International Finance Corporation (IFC) with an investment of Rs 4.5 billion. This landmark issuance underlines growing global confidence in India’s ESG-focused infrastructure financing landscape. The SLB features predefined sustainability performance targets, linking..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?